{"version":"1.0","type":"link","title":"Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group.","author_name":"Gandini A 외","author_url":"https://prs-insight.online/author/Gandini%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/109684","thumbnail_width":1200,"thumbnail_height":630}